AMGN

Amgen

$379.33

-5 (-1.3%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 27.02.2026
$350.04
(-7.72%)
Strong Buy: 4
Buy: 10
Hold: 15
Sell: 2
Strong Sell: 1
Description:
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, UNITED STATES, 91320-1799
Fiscal year end:
December
Market capitalization:
$207 Billion
EBITDA:
$16.6 Billion
PERatio:
27.03
EPS:
14.22
Dividend per share:
$9.52
Dividend yield:
2.49%
Beta:
0.472

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+201%
How much will you get:
$3,012
Prices dates:
29-01-2016: $113.51 and 30-01-2026: $341.88